sinc
initi
descript
kohler
milstein
monoclon
antibodi
made
profound
impress
area
biolog
research
biotechnolog
basic
properti
monoclon
antibodi
combin
specif
one
epitop
famili
relat
epitop
use
suppli
wealth
data
singl
monoclon
antibodi
provid
inform
protein
related
structur
function
synthesi
process
cellular
tissu
distribut
associ
molecul
attempt
separ
way
data
gather
must
extent
artifici
sinc
one
studi
frequent
yield
result
relev
area
howev
appropri
differenti
broad
area
virolog
investig
contribut
monoclon
antibodi
within
area
assess
thu
diagnost
virolog
taxonomi
epidemiolog
section
consid
separ
biochem
molecular
biolog
investig
describ
section
section
iv
deal
interact
viru
host
whole
organ
level
consequ
select
viru
variant
dealt
section
inform
concern
protein
structur
function
obtain
also
section
iv
pathogenesi
investig
intend
review
provid
exhaust
list
public
monoclon
antibodi
use
rather
illustr
monoclon
antibodi
appli
virolog
review
differ
aspect
recent
publish
antczak
blann
kennett
nowinski
et
al
sinkov
dreesman
yewdel
gerhard
import
emphas
monoclon
antibodi
techniqu
rare
appli
isol
normal
back
investig
use
classic
biochem
approach
instanc
recognit
separ
activ
site
hemagglutin
neuraminidas
activ
sendai
viru
hn
protein
portner
involv
experi
use
temperaturesensit
mutat
chemic
inhibitor
well
competit
antibodi
bind
assay
select
viru
variant
proof
relationship
turkey
influenza
swine
virus
involv
rnarna
hybrid
replic
studi
well
observ
monoclon
antibodi
cross
reaction
hinshaw
et
al
furthermor
limit
inform
antibodi
studi
provid
structur
studi
instanc
ultim
depend
orient
antibodi
bind
site
variou
structur
level
protein
amino
acid
sequenc
threedimension
structur
even
intermolecular
associ
section
principl
monoclon
antibodi
product
fuse
short
live
antibodyproduc
cell
deriv
immun
anim
perman
myeloma
cell
line
well
known
recent
review
gerhard
et
al
howev
necessari
consid
product
immunogen
sinc
may
necessari
enrich
preferenti
expos
particular
antigen
thu
product
measl
virusspecif
antibodi
bohn
et
al
heat
antigen
presenc
sodium
dodecyl
sulfat
sd
led
deriv
antibodi
specif
matrix
protein
similar
treatment
presenc
reduc
agent
favour
product
antibodi
direct
phosphoprotein
p
nucleocapsid
protein
n
protein
monoclon
antibodi
desir
suffici
immunogen
necessari
use
pure
prepar
whole
cell
antigen
use
product
antibodi
direct
respiratori
synciti
viru
rsv
cgte
et
al
polyoma
viru
antigen
dilworth
griffin
also
cross
react
eg
group
specif
antibodi
requir
possibl
perform
primari
inocul
one
antigen
boost
inocul
cross
react
antigen
gerhard
et
al
appropri
consid
immunolog
techniqu
use
detail
interest
reader
refer
review
techniqu
use
conjunct
polyclon
sera
van
regenmortel
howev
relev
consid
limit
process
appli
monoclon
antibodi
first
major
monoclon
antibodi
dc
caus
immunoprecipit
antigen
combin
may
relat
fact
one
epitop
recogn
per
molecul
consequ
extens
cross
link
stabil
immun
complex
possibl
therefor
immunoprecipit
monoclon
antibodi
requir
addit
crosslink
agent
staphylococcu
protein
antiimmunoglobulin
antigen
retain
one
bind
site
strongli
combin
monoclon
antibodi
succeed
problem
may
diminish
case
multimer
protein
second
immun
precipit
procedur
involv
use
deterg
precipit
buffer
necessari
prevent
nonspecif
contamin
precipit
howev
deterg
destabil
effect
protein
structur
monoclon
antibodi
often
sensit
minor
conform
chang
section
b
consequ
may
render
nonreact
test
may
necessari
experi
deterg
type
concentr
order
achiev
satisfactori
precipit
specif
monoclon
antibodi
compar
hyperimmun
serum
illustr
fig
advers
effect
alter
protein
conform
may
aggrav
western
blot
procedur
antigen
often
total
denatur
separ
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
test
antibodi
towbin
et
al
howev
method
applic
braun
et
al
roseto
et
al
immun
precipit
suitabl
quantit
antigen
type
inform
extract
radioimmunoassay
ria
enzymelink
immunosorb
assay
elisa
process
extens
appli
initi
screen
success
product
monoclon
antibodi
diagnost
virolog
section
modifi
form
competit
bind
assay
section
procedur
score
combin
antibodi
antigen
give
inform
natur
antigen
deterg
condit
frequent
milder
use
immunoprecipit
attach
antigen
solid
support
necessari
mani
case
test
result
conform
alter
bruck
et
al
inform
histolog
intracellular
locat
antigen
obtain
techniqu
immun
fluoresc
immun
electron
microscopi
iem
use
electrondens
enzymat
marker
review
van
regenmortel
techniqu
wide
use
diagnost
virolog
section
ii
well
studi
viral
protein
synthesi
viru
matur
section
b
addit
tradit
techniqu
serolog
neutral
nt
hemagglutin
inhibit
hi
complement
fixat
cf
hemolysin
inhibit
hli
extens
employ
follow
shown
applic
techniqu
experi
util
monoclon
antibodi
made
studi
area
virolog
research
reaction
singl
antibodi
epitop
character
equilibrium
constant
combin
reflect
bind
assay
describ
section
although
one
antibodi
elicit
exposur
epitop
immun
system
react
mani
epitop
greater
lesser
extent
depend
degre
fit
wouldb
target
site
antigen
combin
site
antibodi
practic
term
epitop
must
possess
form
similar
parent
epitop
combin
detect
vero
cell
infect
measl
viru
edmonston
label
methionin
lysat
prepar
use
immunoprecipit
experi
protein
immunoprecipit
track
rabbit
hyperimmun
antimeasl
serum
track
rabbit
preimmun
control
serum
track
monoclon
antibodi
specif
h
protein
track
monoclon
antibodi
specif
nprotein
track
monoclon
antibodi
specif
matrix
protein
track
control
monoclon
antibodi
rais
coronaviru
antigen
track
total
infect
cell
lysat
without
immunoprecipit
note
antibodi
use
track
strongli
mutual
competit
radioimmunoassay
competit
bind
experi
one
also
activ
immunoprecipit
reaction
reproduc
permiss
carter
et
al
natur
london
abl
bind
assay
specif
reaction
provid
basi
detect
subtl
differ
gene
product
relat
virus
thu
differenti
one
viru
anoth
alter
effici
one
antibodi
combin
target
constitut
small
part
overal
reaction
polyclon
antiserum
antigen
consequ
detect
use
antibodi
uniform
specif
thu
permit
fine
analysi
epitopeantibodi
interact
therefor
structur
alter
target
molecul
inde
approach
greatli
exce
convent
serolog
specif
led
recognit
differ
virus
previous
thought
ident
monoclon
antibodi
capabl
detect
differ
one
amino
acid
formerli
demonstr
recours
peptid
fingerprint
oligonucleotid
map
viral
genom
approach
therefor
revolution
techniqu
viru
identif
provid
mani
case
simplif
test
procedur
yield
rapid
result
use
way
monoclon
antibodi
find
applic
two
main
area
first
field
rapid
diagnosi
viru
diseas
man
anim
plant
second
extens
viru
taxonomi
investig
could
lead
effect
vaccin
program
diseas
treatment
greater
understand
relationship
virus
evolut
epidemiolog
rapid
accur
diagnosi
viral
infect
obviou
import
clinician
public
health
wand
et
al
summar
criteria
select
monoclon
antibodi
use
diagnost
reagent
follow
high
affin
antigen
permit
effici
combin
low
concentr
antigen
effici
displac
host
antibodi
may
alreadi
coat
primari
biopsi
sampl
may
direct
toward
area
molecul
normal
recogn
effici
host
antibodi
therefor
mask
antibodi
direct
often
repeat
antigen
determin
readili
access
eg
viru
coat
protein
multival
may
increas
sensit
igm
found
effect
igg
antibodi
care
chosen
may
give
less
satisfactori
result
usual
serolog
procedur
phillip
et
al
cross
reaction
host
cell
polypeptid
care
exclud
fujinami
et
al
applic
monoclon
antibodi
diagnosi
illustr
refer
follow
virus
herp
hepat
b
rabi
flavivirus
picornavirus
influenza
list
exhaust
cytomegaloviru
human
herpesviru
human
beta
herpesviru
gain
promin
recent
year
follow
latent
viru
reactiv
diseas
immunosuppress
organ
transplant
recipi
patient
immun
defici
syndrom
peterson
et
al
thoma
et
al
b
recent
monoclon
antibodi
develop
direct
viru
structur
polypeptid
pereira
et
al
proven
abl
detect
cmv
infect
biopsi
specimen
test
antibodi
specif
herp
simplex
virus
type
balachandran
et
pereira
et
al
showalt
et
al
also
use
type
virus
directli
cell
herpet
lesion
balachandran
et
al
peterson
et
al
test
yield
ident
result
time
consum
process
viru
isol
type
restrict
endonucleas
map
result
superior
obtain
standard
serolog
similar
procedur
also
prove
success
identif
varicella
zoster
human
herpesviru
cell
obtain
vesicular
skin
lesion
forghani
et
al
monoclon
antibodi
avail
could
use
type
epstein
barr
viru
human
gamma
herpesviru
muellerlantzsch
et
al
herp
virus
also
distinguish
rapid
enzym
immun
filtrat
test
richman
et
al
marek
diseas
md
viru
herp
viru
chicken
normal
diagnos
refer
antisera
direct
marek
associ
tumor
surfac
antigen
matsa
monoclon
antibodi
obtain
lee
et
al
specif
matsa
andus
success
identif
marek
diseas
chicken
lee
et
al
use
test
help
prevent
confus
lymphoid
leukosi
sinc
diseas
produc
similar
symptom
econom
import
monoclon
antibodi
produc
hepat
b
viru
hbv
wand
et
al
use
obtain
similar
improv
sensit
convent
diagnosi
applic
monoclon
antibodi
ria
found
detect
hbv
surfac
antigen
even
patient
neg
convent
test
subsequ
confirm
demonstr
new
test
detect
antigenantibodi
complex
invis
former
procedur
complex
shown
viru
relat
dna
hybrid
techniqu
shafritz
et
al
four
serotyp
dengu
viru
distinguish
monoclon
antibodi
appli
success
identif
fresh
low
passag
viru
isol
test
henchal
et
al
found
reliabl
faster
usual
plaqu
reduct
test
influenza
b
virus
could
readili
distinguish
case
type
satisfactorili
even
insuffici
viru
present
permit
hemagglutin
inhibit
test
final
monoclon
antibodi
may
find
widespread
futur
use
diagnosi
plant
viru
diseas
recent
work
antibodi
specif
tobacco
mosaic
viru
abl
distinguish
two
orchid
strain
previous
thought
ident
tabomaviru
type
strain
briand
et
al
use
monoclon
antibodi
wider
aspect
diagnosi
review
nowinski
et
al
applic
monoclon
antibodi
viru
identif
made
field
viru
epidemiolog
taxonomi
manner
antibodi
permit
fine
analysi
interviru
relationship
structur
biolog
level
monoclon
antibodi
use
compar
vaccin
strain
yellow
fever
viru
yfv
deriv
differ
laboratori
confirm
requir
similar
vaccin
use
strain
could
also
differenti
virul
field
isol
similar
comparison
wild
type
polio
viru
andvaccin
strain
saukett
sabin
also
conduct
crainic
et
al
ferguson
et
al
humphrey
et
al
minor
et
al
osterhau
et
al
use
monoclon
antibodi
studi
rabi
infect
provid
import
insight
mechan
viru
pathogen
section
iv
variat
viru
strain
mani
worker
compar
field
isol
use
monoclon
antibodi
direct
viru
glycoprotein
nucleocapsid
protein
way
differ
found
virus
previous
consid
ident
charlton
et
al
digoutt
schneider
witkor
koprowski
may
import
bear
instanc
vaccin
failur
observ
variat
nucleocapsid
protein
probabl
import
respect
charlton
et
al
differ
also
exist
morbillivirus
giraudon
wild
b
server
et
al
ter
meulen
et
al
addit
monoclon
antibodi
permit
analysi
similar
differ
hapadnavirus
et
al
parvovirus
burtonboy
et
al
parrish
et
al
rotavirus
gari
et
al
greenberg
et
al
bunyavirus
gonzalezscarano
et
al
identifi
zinga
viru
rift
valley
fever
meegan
et
al
present
time
viru
best
character
monoclon
antibodi
influenza
threedimension
structur
determin
hemagglutinin
ha
neuraminidas
na
section
iii
mainten
influenza
within
human
popul
relat
two
mechan
first
exchang
hemagglutinin
gene
one
deriv
anim
viru
accomplish
complet
antigen
chang
antigen
shift
viru
permit
widespread
human
infect
preexist
immun
thu
overcom
worldwid
pandem
may
result
period
antigen
shift
gradual
alter
occur
viru
protein
antigen
drift
case
may
permit
reinfect
host
popul
monoclon
antibodi
natur
appli
interest
phenomena
attempt
demonstr
relationship
human
anim
avian
viru
speci
also
demonstr
antigen
drift
field
laboratori
monoclon
antibodi
provid
sensit
requir
analyz
subtl
structur
alter
therefor
well
suit
task
seal
influenza
viru
compar
virus
avian
origin
close
relationship
note
hemagglutinin
molecul
sourc
suggest
avian
virus
might
play
role
evolut
seal
viru
strain
studi
differ
note
avian
influenza
strain
may
relat
origin
host
fukushi
et
al
differ
observ
neuraminidas
na
molecul
holm
et
al
antigen
drift
demonstr
among
field
isol
influenza
underwood
b
addit
nonneutr
ha
na
variant
readili
select
use
monoclon
antibodi
appli
select
pressur
natali
et
al
webster
et
al
demonstr
process
might
occur
immunolog
pressur
appli
host
least
laboratori
select
variant
might
abl
spread
popul
sinc
neutral
mani
sampl
sera
potenti
host
recogn
parent
viru
natali
et
al
contrast
readi
demonstr
variabl
among
influenza
virus
tickborn
enceph
viru
tbe
isol
remain
similar
last
year
heinz
et
ab
readi
differenti
virus
permit
analysi
viru
spread
within
popul
least
two
variant
influenza
b
could
coexist
popul
respect
epidemiolog
herp
simplex
viru
also
studi
one
patient
may
suffer
virus
simultan
peterson
et
al
monoclon
antibodi
permit
analysi
mix
infect
close
relat
virus
uitro
thu
interfer
exclus
demonstr
dengu
viru
type
small
proport
cell
could
doubli
infect
dittmar
et
al
use
reagent
permit
identif
polypeptid
carri
viru
taxonom
marker
group
type
etc
demonstr
simian
agent
adenoviru
russel
et
al
herp
viru
mclean
et
showalt
et
al
type
analysi
could
also
indic
polypeptid
structur
conserv
cours
viru
evolut
advantg
techniqu
permit
rapid
effici
viru
identif
enorm
howev
essenti
monoclon
antibodi
chosen
care
mani
recogn
carbohydr
determin
glycosyl
polypeptid
modif
influenc
host
cell
viru
grown
klenk
rott
least
one
instanc
known
typespecif
target
present
hsv
glycoprotein
synthes
cell
reactiv
viru
grown
vero
cell
second
abil
detect
differ
influenc
techniqu
use
kendal
et
al
bind
monoclon
antibodi
antigen
may
may
disrupt
biolog
function
protein
could
lead
error
test
involv
monitor
antibodi
bind
indirectli
inhibit
target
protein
function
reason
procedur
simpli
demonstr
antibodi
bind
prefer
diagnost
virolog
immunofluoresc
method
choic
purpos
sinc
rapid
rel
simpl
furthermor
applic
directli
biopsi
sampl
provid
addit
inform
histolog
distribut
antigen
examin
howev
bind
alon
insuffici
guid
research
purpos
sinc
function
signific
epitop
may
vari
viru
strain
mutat
may
render
antibodi
unabl
inhibit
protein
function
without
abolish
antibodi
bind
kendal
et
al
necessari
therefor
perform
number
test
order
extract
maximum
possibl
inform
monoclon
antibodi
provid
us
tool
abl
examin
individu
protein
within
structur
complic
whole
cell
possibl
investig
uitro
viuo
role
protein
also
possibl
determin
activ
area
molecul
monitor
synthesi
process
within
infect
cell
abil
distinguish
relat
protein
use
provid
genet
marker
recombin
experi
gonzalezscarano
et
al
combin
antibodi
antigen
use
provid
structur
inform
sever
level
first
possibl
identifi
protein
carri
taxonom
marker
possibl
identifi
protein
perform
particular
function
antibodi
avail
capabl
inhibit
function
second
antibodi
bind
target
protein
differ
capac
produc
function
inhibit
protein
panel
monoclon
antibodi
frequent
divid
group
accord
effect
activ
target
protein
famili
protein
way
epitop
may
assign
function
signific
certain
assumpt
made
possibl
conduct
competit
bind
analys
arrang
antibodi
site
rel
schemat
map
molecul
surfac
drawn
frequent
viru
variant
select
given
antibodi
longer
bind
may
also
analyz
loss
protein
function
loss
capac
bind
monoclon
antibodi
way
map
refin
inde
construct
entir
third
order
explain
function
term
structur
necessari
orient
map
thu
obtain
physic
structur
antigen
done
determin
amino
acid
alter
produc
variant
describ
either
directli
partial
proteolysi
examin
molecul
fragment
bound
antibodi
genom
sequenc
determin
region
alter
activ
amino
acid
residu
thu
distinguish
posit
primari
structur
protein
locat
antibodi
bind
site
known
threedimension
structur
protein
determin
clue
may
obtain
immun
electron
microscopi
iem
whole
process
describ
met
vari
success
applic
number
virus
complet
determin
deriv
studi
influenza
viru
hemagglutinin
neuraminidas
target
protein
monoclon
antibodi
usual
detect
radioimmun
precipit
western
blot
procedur
section
manner
protein
neutral
antibodi
direct
determin
eg
polioviru
osterhau
et
al
thorp
et
al
bluetongu
viru
letchworth
appleton
gp
venezuelan
equin
enceph
viru
roehrig
et
glycoprotein
coronaviru
mhv
proven
respons
cell
attach
viru
spread
cellcel
fusion
collin
et
al
modifi
immunoprecipit
experi
demonstr
subset
antigen
present
infect
cell
abl
bind
viru
origin
dna
replic
antibodi
use
work
appar
capabl
distinguish
antigen
activ
antigen
could
perform
function
scheller
et
al
similar
analysi
identifi
cellular
rna
polymeras
bind
adenoviru
promotor
vitro
dahmu
keding
microinject
techniqu
demonstr
antibodi
specif
transform
relat
protein
cell
capabl
prevent
seruminduc
onset
dna
synthesi
mercer
et
al
although
last
two
experi
concern
function
cellular
protein
approach
obviou
applic
studi
viru
replic
transcript
approach
could
also
investig
involv
host
cell
protein
process
insight
function
tumour
viru
protein
transform
cell
surviv
come
work
involv
monoclon
antibodi
specif
e
structur
compon
type
c
retrovirus
protein
detect
cancer
effus
found
highli
effici
block
monocyt
respons
chemoattract
function
could
protect
cancer
attack
cianciolo
et
al
analysi
seek
defin
activ
area
protein
term
epitop
recogn
panel
monoclon
antibodi
main
experi
conduct
viru
surfac
protein
easili
monitor
biolog
function
hemagglutin
neutral
hemolysi
neuraminidas
activ
principl
approach
could
extend
protein
measur
activ
combin
antibodi
antigen
varieti
effect
depend
site
attach
function
might
previous
thought
associ
found
separ
highli
specif
monoclon
antibodi
use
polyclon
monospecif
serum
coat
protein
surfac
antibodi
normal
inhibit
protein
function
monoclon
antibodi
bind
away
activ
site
need
detect
effect
burstin
et
al
massey
schochetman
pinter
et
al
thorp
et
al
mean
function
inhibit
analysi
panel
monoclon
antibodi
specif
measl
viru
hemagglutinin
divid
five
group
group
antibodi
detect
activ
hi
nt
assay
group
exhibit
hi
activ
fail
neutral
viru
group
consist
antibodi
similar
activ
test
antibodi
group
reveal
significantli
higher
activ
hi
nt
test
wherea
revers
group
antibodi
use
studi
deliber
select
undetect
hli
activ
report
therefor
document
separ
hemagglutin
model
viru
attach
target
cell
hemolysi
model
viru
penetr
fusion
reaction
indic
requir
underli
reaction
must
differ
test
fact
artifici
sinc
viru
normal
act
cross
link
cell
lyse
cell
attack
result
indic
possibl
prevent
stabl
cell
cross
link
circumst
still
permit
suffici
viruscel
associ
action
fusion
protein
similarli
antibodi
may
inhibit
hemagglutin
still
permit
suffici
cell
contact
infect
inhibit
burstin
et
al
gentri
et
al
gonzalezscarano
et
al
kimurakiroda
yasui
ter
meulen
et
al
type
analysi
provid
clue
function
area
multifunct
protein
distinct
instanc
paramyxoviru
hn
protein
two
activ
cell
attach
neuraminidas
probabl
resid
differ
area
molecul
sinc
monoclon
antibodi
inhibit
neuraminidas
orvel
grandien
viru
variant
obtain
monoclon
antibodi
select
pressur
defici
neuraminidas
portner
way
antibodi
known
neutral
viru
without
block
hemagglutin
presum
antibodi
bind
site
import
viru
penetr
absorpt
phenomenon
exemplifi
sendai
viru
miura
et
al
influenza
viru
sindbi
viru
chana
et
al
reoviru
burstin
et
al
biolog
function
use
character
epitop
defin
competit
elisa
envelop
glycoprotein
bovin
leukemia
viru
bruck
et
al
analysi
concentr
blv
vsv
pseudotyp
format
inhibit
polykaryotosi
inhibit
cellcel
fusion
follow
infect
complement
fixat
bruck
et
al
monoclon
antibodi
direct
viru
surfac
protein
gener
readili
produc
becom
avail
specif
viru
intern
protein
approach
expect
yield
inform
function
function
inhibihon
assay
appli
delin
area
antigen
involv
atpas
activ
clark
et
demonstr
area
influenza
vsv
nucleocapsid
protein
may
associ
transcript
process
de
et
al
van
wyke
et
epitop
identifi
necessari
determin
topolog
relationship
surfac
molecul
conveni
achiev
competit
bind
analysi
although
select
variant
also
extens
use
competit
bind
frequent
examin
ria
elisa
one
monoclon
antibodi
carri
appropri
marker
unlabel
antibodi
assess
capac
inhibit
combin
label
antibodi
antigen
competit
observ
antibodi
said
belong
bind
group
howev
sever
precaut
must
taken
interpret
data
meaning
conclus
reach
assum
two
antibodi
mutual
competit
bind
site
overlap
bind
site
second
antibodi
wholli
partial
mask
bind
first
antibodi
bind
truli
competit
natur
howev
explan
observ
bind
site
may
distinct
close
togeth
bulk
first
antibodi
molecul
steric
prevent
access
second
bind
site
two
possibl
readili
distinguish
least
impli
proxim
attach
site
fact
monoclon
antibodi
bound
singl
epitop
target
protein
may
consider
swivel
movement
avail
render
steric
effect
rel
unimport
stone
nowinski
report
two
igg
molecul
mw
could
bind
noncompetit
retroviru
protein
howev
immunoglobulin
class
may
well
import
sinc
oligomer
igm
would
obvious
provid
greater
steric
hindranc
igg
steric
effect
suspect
may
minim
use
monomer
antigenbind
submolecular
antibodi
fragment
howev
quit
possibl
alloster
inhibitori
effect
might
also
occur
would
indistinguish
true
competit
bind
inde
posit
alloster
effect
observ
antibodi
pair
identifi
bind
synergist
lefrancoi
lyle
b
lubeck
gerhard
similar
effect
result
competit
may
widespread
difficult
demonstr
combin
monoclon
antibodi
influenza
neuraminidas
modifi
reaction
kinet
mountford
et
al
combin
hsv
glycoprotein
alter
pattern
obtain
partial
proteolysi
eisenberg
et
al
effect
could
also
mediat
antibodyinduc
conform
chang
final
two
antibodi
direct
site
compet
manner
relat
rel
avid
concentr
take
extrem
case
weakli
bind
antibodi
would
show
detect
competit
label
strongli
bind
immunoglobulin
revers
clearli
true
practic
spectrum
rel
interfer
effici
probabl
obtain
lefrancoi
lyle
b
stone
nowinski
extent
interfer
obtain
influenc
antibodi
avid
well
proxim
bind
site
reason
bind
site
distinguish
basi
extent
competit
observ
competit
signific
furthermor
observ
competit
assign
two
antibodi
bind
group
suffici
separ
mere
basi
failur
compet
noncompet
antibodi
examin
revers
experi
ie
partner
carri
marker
exclud
avid
effect
describ
procedur
fail
reveal
competit
alloc
separ
bind
group
justifi
altern
determin
antibodi
avid
may
obviat
need
analysi
oneway
competit
effect
still
occur
even
case
antibodi
similar
avid
concentr
carter
et
al
reason
unknown
might
involv
form
alloster
effect
determin
antibodi
avid
may
perform
rapid
method
jackson
et
al
rel
antibodi
avid
may
estim
ria
satur
curv
carter
et
al
massey
schochetman
stone
nowinski
competit
bind
procedur
appli
success
mani
virus
monoclon
antibodi
specif
measl
viru
hemagglutinin
group
five
set
basi
abil
influenc
biolog
function
molecul
sort
three
bind
group
competit
radioimmunoassay
carter
et
ul
similar
approach
produc
detail
map
vsv
g
protein
includ
epitop
instrument
viru
neutral
determin
identifi
crossreact
specif
strain
indiana
new
jersey
lefrancoi
lyle
b
volk
et
al
japanes
enceph
viru
kimurakiroda
yasui
rna
tumor
virus
bruck
et
al
b
massey
schochetman
niman
elder
pinter
et
al
also
extens
analyz
bind
group
analysi
form
sensit
probe
alter
protein
surfac
structur
manner
sampl
prepar
also
influenc
conform
andor
exposur
react
epitop
consid
design
experi
bruck
et
al
second
approach
problem
arrang
bind
site
rel
select
viru
variant
monoclon
antibodi
select
pressur
case
neutral
antibodi
rel
straightforward
nonneutr
antibodi
could
also
appli
envelop
virus
use
conjunct
complement
viru
variant
may
isol
select
antibodi
longer
bind
antibodi
combin
longer
result
neutral
virus
test
panel
monoclon
antibodi
determin
antibodi
also
show
alter
bind
characterist
way
map
epitop
construct
viru
variant
commonli
alreadi
present
popul
frequenc
emini
et
al
portner
et
al
prabhakar
et
al
webster
et
al
presum
repres
error
rate
viru
transcript
result
amino
acid
substitut
either
within
antibodi
bind
site
posit
influenc
structur
bind
site
type
experi
provid
finer
analysi
relationship
bind
site
steric
hindranc
elimin
variant
select
map
appli
main
ha
na
protein
influenza
extrem
detail
studi
perform
laver
et
al
laver
et
al
gerhard
et
al
exemplifi
approach
howev
regardless
method
epitop
topographi
determin
schemat
map
thu
produc
must
orient
physic
structur
protein
necessit
detail
knowledg
molecul
two
approach
use
achiev
object
first
antibodi
bind
site
local
particular
peptid
fragment
follow
partial
proteolysi
second
amino
acid
substitut
occur
antibodyselect
variant
protein
determin
niman
elder
conduct
comprehens
analysi
rauscher
viru
gp
product
partial
proteolysi
identifi
reactiv
antisera
direct
synthet
polypeptid
predict
gene
sequenc
polypeptid
assign
peptid
map
way
linear
proteolyt
leavag
map
could
deriv
differ
enzym
monoclon
antibodi
analyz
abil
immunoprecipit
variou
polypeptid
fragment
bind
site
could
assign
molecul
primari
structur
found
antibodi
bind
site
close
group
two
area
presum
reflect
region
protein
expos
immunolog
attack
similar
analysi
locat
eight
epitop
previous
defin
reaction
panel
monoclon
antibodi
proteolyt
cleavag
map
gp
murin
leukemia
viru
pinter
et
al
antibodi
site
also
local
gp
bovin
leukemia
viru
molecular
weight
fragment
contain
area
involv
biolog
activ
bruck
et
al
similarli
herp
simplex
viru
glycoprotein
type
common
determin
local
fragment
larger
peptid
also
contain
two
typespecif
determin
eisenberg
et
al
studi
locat
activ
site
antigen
atpas
mean
well
character
delet
mutant
found
enzym
activ
antibodi
bind
requir
region
gene
map
unit
clark
et
al
provid
primari
sequenc
molecul
known
viru
variant
suppli
highli
specif
inform
locat
antibodi
bind
site
unlik
antibodi
bind
peptid
fragment
howev
possibl
absolut
certain
amino
acid
affect
actual
constitut
part
bind
site
method
extens
appli
studi
influenza
amino
acid
alter
detect
peptid
map
laver
et
al
laver
et
al
genom
sequenc
caton
et
al
sinc
threedimension
structur
influenza
hemagglutinin
avail
bind
site
could
easili
locat
analog
model
permit
locat
site
strain
influenza
caton
et
ul
jackson
et
al
studi
reveal
presenc
distinct
area
ha
molecul
within
amino
acid
substitut
predominantli
occur
area
also
implic
product
antigen
variat
associ
process
antigen
drift
review
ward
threedimension
structur
influenza
viru
na
molecul
known
permit
locat
monoclon
antibodi
bind
site
identifi
also
provid
insight
area
molecul
involv
enzym
function
previous
identifi
monoclon
antibodi
well
locat
antigen
drift
could
occur
level
refin
knowledg
structur
function
antigen
far
reach
influenza
similar
approach
locat
neutral
site
polioviru
type
found
small
eight
amino
acid
sequenc
protein
minor
et
al
howev
threedimension
structur
yet
avail
viru
clue
antibodi
bind
site
locat
may
obtain
immun
electron
microscopi
antibodi
use
conjunct
electrondens
materi
ferritin
hemocyanin
gonda
et
al
chana
et
al
demonstr
hemagglutin
inhibit
monoclon
antibodi
attach
near
tip
sindbi
viru
peplom
hemolysin
inhibit
antibodi
attach
lower
near
viru
membran
similar
situat
also
demonstr
influenza
may
explain
separ
hemagglutin
inhibit
neutral
exhibit
monoclon
antibodi
specif
ha
protein
seal
influenza
way
monoclon
antibodi
provid
sensit
probe
viru
detect
diagnosi
section
also
use
detect
low
amount
individu
viru
protein
within
infectedcel
way
answer
question
molecular
cell
biolog
thu
provid
inform
concern
tempor
spatial
separ
protein
format
accumul
data
protein
modif
process
infect
cell
mani
studi
perform
demonstr
tempor
control
protein
synthesi
within
lytic
viru
infect
eg
sendai
viru
orvel
grandien
measl
viru
norrbi
et
al
object
review
list
studi
rather
shall
consid
persist
infect
normal
protein
synthesi
modifi
control
viru
cell
may
coexist
interest
inform
gather
area
frequent
involv
low
level
infect
cell
protein
within
cell
monoclon
antibodi
thu
admir
suit
investig
phenomenon
measl
viru
associ
persist
slowli
progress
fatal
infect
human
central
nervou
system
cn
term
subacut
scleros
panenceph
sspe
review
ter
diseas
associ
failur
produc
matur
viru
develop
typic
measl
viru
cytopatholog
cell
fusion
brain
tissu
examin
patient
immun
respons
ill
demonstr
lack
antibodi
direct
viru
matrix
protein
direct
search
immunoprecipit
western
blot
techniqu
fail
demonstr
product
protein
infect
brain
brain
explant
clinic
import
diseas
prompt
examin
measl
viru
polypeptid
express
persist
infect
cell
uitro
studi
use
sever
monoclon
antibodi
fail
detect
protein
persist
infect
tissu
cultur
cell
line
sspe
cell
line
deriv
sspe
patient
brain
carter
et
al
although
method
permit
identif
protein
laboratoryestablish
persist
infect
previous
thought
express
polypeptid
monoclon
antibodi
thu
provid
excel
evid
matrix
protein
synthes
sspe
cell
line
lack
major
structur
polypeptid
thought
prevent
viru
particl
matur
account
slowli
progress
natur
diseas
measl
viru
persist
infect
cell
show
low
express
membran
glycoprotein
norrbi
et
al
although
express
normal
suffici
permit
develop
syncytia
express
viru
polypeptid
also
investig
within
mous
brain
persist
infect
lymphocyt
choriomening
lcm
viru
oldston
buchmeier
rodriguez
et
al
sendai
viru
surfac
spleen
cell
mice
infect
friend
leukemia
viru
britt
et
al
case
level
viru
glycoprotein
detect
cell
surfac
also
reduc
perhap
one
way
persist
infect
cell
evad
immun
system
thu
permit
mainten
infect
monoclon
antibodi
permit
select
detect
virusspecif
transform
marker
transform
cell
surfac
eg
epstein
barr
viru
kintner
sugden
slovin
et
al
marek
diseas
viru
lee
et
al
antibodi
permit
detect
character
transform
specif
protein
well
investig
function
monoclon
antibodi
direct
vra
gene
product
harvey
sarcoma
viru
produc
product
vrcz
gene
famili
virus
transform
normal
cell
shown
share
similar
antibodi
abl
confirm
protein
locat
inner
surfac
membran
bind
guanin
nucleotid
furth
et
al
addit
tumor
antigen
adenoviru
shown
accumul
cell
nucleu
sarnow
et
al
specif
monoclon
antibodi
confer
abil
react
famili
relat
protein
properti
particularli
relev
precursorproduct
relationship
exist
proteolysi
similar
sequenc
protein
might
occur
differ
molecul
eg
follow
recombin
readthrough
event
transcript
precursor
never
reach
appreci
level
within
cell
share
sequenc
small
cross
react
protein
difficult
detect
polyclon
serum
small
virusspecif
polypeptid
react
monoclon
antibodi
specif
glycoprotein
b
detect
hsvinfect
vero
cell
pereira
et
al
identifi
virusinfect
cell
later
shown
proteolyt
relat
intact
form
glycoprotein
pereira
et
al
famili
relat
protein
also
detect
manner
cmv
infect
cell
cleavag
product
measl
viru
nucleocapsid
protein
also
identifi
carter
baczko
type
analysi
defin
aprotein
famili
indic
whether
submolecular
fragment
serv
purpos
furthermor
care
alway
taken
ensur
protein
precipit
caus
spuriou
cross
reaction
host
cell
polypeptid
section
v
monoclon
antibodi
also
permit
identif
novel
viru
protein
new
cell
surfac
marker
discov
b
cell
line
known
harbor
ebv
slovin
et
al
new
hsv
glycoprotein
also
detect
character
balachandran
et
al
new
protein
gp
detect
leukem
cell
mice
infect
friend
leukemia
viru
protein
appar
deriv
viru
produc
recombin
event
infect
lost
cross
reactiv
monoclon
antibodi
specif
ecotrop
friend
murin
leukemia
viru
britt
et
al
unusu
form
composit
protein
demonstr
measl
viru
infect
bgm
cell
appar
produc
infect
cell
protein
detect
crossreact
monoclon
antibodi
specif
nucleocapsid
protein
new
molecul
larger
peptid
map
analysi
show
appar
contain
nucleocapsid
peptid
plu
new
one
whose
origin
could
determin
wild
giraudon
precursor
product
relationship
could
demonstr
new
protein
nucleocapsid
protein
origin
protein
still
obscur
readthrough
mechan
suggest
similar
find
also
report
use
monoclon
antibodi
studi
hsv
infect
zweig
et
al
polypeptid
observ
larger
nucleocapsid
protein
contain
addit
peptid
appar
precursorproduct
relationship
smaller
nucleocapsid
protein
follow
synthesi
protein
may
matur
posttransl
process
process
sens
use
includ
coval
modif
glycosyl
posttransl
cleavag
etc
well
matur
conform
chang
often
associ
format
intermolecular
associ
concept
particularli
relev
context
viru
assembl
stabl
associ
must
occur
lead
product
viabl
particl
conform
chang
probabl
involv
process
may
perform
regulatori
function
tobacco
mosaic
viru
assembl
butler
klug
durham
modif
transport
novel
protein
form
proteolysi
hsvinfect
cell
alreadi
mention
section
iii
protein
degrad
cell
type
pereira
et
al
suggest
process
function
import
process
phenomenon
howev
monoclon
antibodi
use
pulsechas
experi
demonstr
genuin
modif
protein
glycosyl
balachandran
et
al
also
demonstr
tempor
regul
synthesi
showalt
et
al
misra
et
al
studi
matur
earli
glycoprotein
worker
discov
tunicamycinsensit
glycosyl
necessari
cell
surfac
express
protein
howev
monoclon
antibodi
may
react
unmodifi
form
protein
one
antibodi
panel
direct
measl
viru
h
protein
react
unmodifi
product
form
vitro
j
carter
unpublish
observ
consequ
might
alway
provid
adequ
probe
express
polypeptid
moieti
polyclon
serum
therefor
alway
use
opposit
result
obtain
measl
viru
h
protein
glycosyl
requir
insert
rough
endoplasm
reticulum
intracellular
transport
protein
plasma
membran
detail
studi
also
elucid
intermedi
form
protein
modif
pathway
lead
matur
molecul
bellini
et
al
comprehens
immunofluoresc
studi
use
monoclon
antibodi
examin
distribut
number
moloney
murin
leukemia
protein
infect
cell
membran
satak
et
al
satak
luftig
worker
abl
demonstr
membran
site
viru
antigen
accumul
often
distinct
differenti
control
cellular
microtubul
system
addit
abl
demonstr
doubl
dot
immunofluoresc
two
virusspecif
antigen
e
accumul
site
associ
gag
env
gene
product
may
import
viru
assembl
format
viru
particl
stabl
intermolecular
associ
must
form
like
protein
combin
form
viru
structur
compon
involv
conform
chang
protein
conform
could
also
alter
artifactu
extract
procedur
although
antibodi
seem
recogn
sequenc
amino
acid
monoclon
antibodi
possess
sensit
conform
epitop
visual
use
polyclon
serum
permit
investig
complex
field
structur
isomer
altern
develop
intermolecular
associ
must
result
mask
epitop
therefor
inhibit
combin
antibodi
direct
toward
area
protein
monoclon
antibodi
could
distinguish
readili
nativ
unfold
form
sindbi
viru
glycoprotein
el
roehrig
et
al
nativ
n
heat
h
form
polioviru
capsid
icenogl
et
al
latter
case
also
shown
irrevers
convers
n
h
could
accomplish
acid
isol
procedur
explain
earlier
find
capsid
h
form
insid
infect
cell
ferguson
et
al
biolog
relev
inform
concern
viru
assembl
also
deriv
studi
polioviru
two
monoclon
antibodi
obtain
bound
poliovirion
precursor
structur
site
recogn
differ
one
antibodi
bound
infecti
virion
empti
capsid
n
form
precursor
subunit
bound
virion
empti
capsid
neither
antibodi
bound
heattreat
particl
furthermor
antibodi
bind
site
shown
locat
chemic
cross
link
neither
antibodi
bound
well
free
nativ
denatur
form
indic
site
recogn
form
capsid
structur
howev
variant
could
readili
select
express
site
like
area
recogn
antibodi
vital
structur
integr
emini
et
al
similar
data
report
foot
mouth
diseas
viru
fmdv
monoclon
antibodi
obtain
distinguish
complet
virion
precursor
subunit
mccullogh
butcher
two
studi
demonstr
uniqu
antigen
site
creat
picornaviru
matur
explain
earlier
report
neutral
antibodi
could
elicit
use
matur
polio
virion
immunogen
dernick
similar
effect
demonstr
case
tmv
monoclon
antibodi
react
nucleocapsid
other
protein
monom
dietzgen
sander
although
former
class
must
recogn
new
site
caus
conform
chang
form
molecular
junction
latter
class
antibodi
could
direct
site
either
mask
protein
complex
destroy
conform
chang
pathway
adenoviru
hexon
polymer
also
investig
conformationspecif
monoclon
antibodi
monomer
denatur
hexon
protein
lack
antigen
determin
common
trimer
capsomer
situat
reminisc
picornaviru
capsid
use
conformationsensit
monoclon
antibodi
cepko
sharp
shown
trimer
hexon
protein
involv
nonstructur
look
virusspecif
polypeptid
three
hexon
molecul
bind
protein
monomer
configur
releas
trimer
capsomer
capsomer
conform
adopt
concomitantli
releas
scaffold
protein
structur
rearrang
may
also
occur
releas
cmv
sinc
antibodi
abl
react
determin
neutral
infecti
viru
unabl
bind
protein
surfac
infect
cell
conform
chang
believ
import
develop
fusion
protein
activ
influenza
viru
hemagglutinin
low
ph
skehel
et
al
monoclon
antibodi
use
demonstr
structur
chang
directli
locat
area
involv
molecul
structur
daniel
et
al
viru
architectur
proxim
structur
protein
also
amen
examin
instanc
gp
gp
shown
close
associ
venezuelan
equin
enceph
vee
viru
envelop
mean
competit
bind
studi
roehrig
et
al
similar
examin
show
influenza
hemagglutinin
close
cellular
histocompat
antigen
surfac
infect
cell
complex
appar
form
sinc
antigen
cocap
hackett
askona
matur
influenza
viru
envelop
howev
ha
protein
often
found
close
associ
na
protein
sinc
monoclon
antibodi
specif
hemagglutinin
may
neuraminidas
inhibit
activ
frequent
virusspecif
product
associ
cellular
protein
demonstr
competit
bind
assay
coprecipit
experi
carrol
gurney
ferracini
et
al
sarnow
et
al
c
mutat
structur
chang
also
result
acquisit
mutat
viru
genom
persist
infect
viru
genom
abl
accumul
mutat
rapidli
holland
et
al
result
structur
alter
viru
protein
detect
monoclon
antibodi
differ
found
glycoprotein
synthes
lytic
transform
ebv
nontransform
viru
shed
persist
infect
chang
also
demonstr
measl
viru
hemagglutinin
immunofluoresc
similar
process
detect
alter
competit
bind
behavior
use
monoclon
antibodi
specif
measl
viru
matrix
protein
studi
appar
separ
bind
group
observ
monoclon
antibodi
found
lost
capac
compet
second
even
though
still
immunoprecipit
protein
exampl
illustr
detect
structur
chang
depend
method
use
examin
base
sole
radioimmun
precipit
may
superior
detect
certain
chang
loosen
protein
render
suscept
action
deterg
buffer
use
howev
chang
rel
avid
topographi
allosteri
would
detect
provid
antibodi
avid
still
suffici
high
permit
precipit
section
similarli
deterg
produc
effect
might
detect
competit
ria
alon
analysi
virusspecif
protein
structur
function
alway
desir
obtain
pure
prepar
protein
question
permit
uitro
experiment
vaccin
product
one
obviou
exampl
use
monoclon
antibodi
put
prepar
affin
column
purif
appropri
list
instanc
perform
review
applic
monoclon
antibodi
technolog
would
incomplet
without
mention
subject
applic
techniqu
exemplifi
purif
glycoprotein
hsv
eisenberg
et
al
measl
viru
hemagglutinin
bellini
et
al
use
ria
elisa
monoclon
antibodi
provid
conveni
accur
method
quantit
viral
protein
lutz
et
al
studi
viru
pathogen
complic
studi
conduct
uitro
examin
frequent
cross
boundari
virolog
immunolog
monoclon
antibodi
may
use
isol
nonneutraliz
viru
variant
alreadi
discuss
section
variant
also
appli
studi
pathogen
well
protein
structur
spontan
viru
variant
occur
high
frequenc
lo
coxsacki
viru
popul
prabhak
et
al
may
explain
high
variat
diseas
pattern
produc
virus
possibl
alter
viru
attach
protein
might
result
alter
tissu
tropism
howev
interest
data
far
emerg
studi
rabi
influenza
viru
select
natur
aris
antigen
variant
rabi
viru
glycoprotein
first
report
coulon
et
al
b
appli
method
select
variant
use
three
monoclon
antibodi
note
two
antibodi
led
isol
variant
indistinguish
virul
parent
viru
stock
one
antibodi
select
avirul
virus
variant
similar
parent
viru
criteria
differ
capac
evok
strong
rapid
immun
respons
could
lead
success
defens
infect
coulon
et
al
monoclon
antibodi
use
locat
virulencerel
epitop
antigen
map
coulon
et
al
similar
experi
led
dietzschold
et
al
identif
singl
amino
acid
chang
nonpathogen
variant
rabi
viru
arginin
residu
present
virul
viru
glycoprotein
posit
substitut
avirul
variant
test
differ
identifi
section
b
posit
viru
protein
broadli
similar
result
also
obtain
studi
reoviru
monoclon
antibodi
neutral
viru
burstin
et
al
use
select
variant
variant
found
exhibit
reduc
neurovirul
compar
parent
strain
alter
epitop
also
demonstr
major
site
recognit
viru
specif
cytotox
lymphocyt
finberg
et
al
use
monoclon
antibodi
studi
antigen
drift
influenza
viru
alreadi
discuss
context
structur
inform
deriv
experi
section
although
antigen
drift
studi
mainli
ha
molecul
natali
et
al
underwood
may
also
occur
neuraminidas
extent
may
restrict
speci
avian
viru
knowledg
basi
drift
approach
ha
molecul
colman
et
az
subject
mention
sinc
direct
bear
pathogenesi
surviv
influenza
virus
popul
role
ha
drift
recent
review
ward
monoclon
antibodi
appli
order
mimic
immun
respons
gain
insight
effect
immunolog
pressur
viru
experi
use
monoclon
antibodi
block
cytotox
lymphocyt
action
demonstr
epitop
recogn
cell
may
ident
finberg
et
al
distinct
lefrancoi
lyle
region
neutral
antibodi
direct
host
immun
respons
implic
mainten
measl
viru
persist
lead
sspe
describ
section
jii
b
diseas
associ
defect
product
viru
protein
evid
gather
suggest
host
immun
respons
may
actual
modul
synthesi
viru
polypeptid
consequ
help
bring
situat
fujinami
oldston
model
uiuo
inocul
hyperimmun
antimeasl
viru
antiserum
found
alter
characterist
diseas
intracerebr
inocul
balbc
mice
delay
diseas
produc
inocul
monoclon
antibodi
specif
viru
hemagglutinin
protein
also
abl
induc
effect
although
monoclon
antibodi
direct
nucleocapsid
protein
could
rammohan
et
al
similar
process
demonstr
measl
viru
persist
infect
uitto
antiserum
treatment
cell
persist
infect
measl
viru
led
drastic
reduct
express
viru
polypeptid
barrett
koschel
monoclon
antibodi
h
n
could
produc
effect
p
n
barrett
person
commun
antibodi
surfac
glycoprotein
also
prolong
experiment
sindbi
viru
infect
chana
et
al
antibodi
neutral
activ
activ
respect
lack
properti
also
reflect
measl
viru
system
describ
monoclon
antibodi
neutral
viru
seem
exclus
activ
produc
alter
viru
polypeptid
express
p
n
barrett
person
commun
howev
also
true
circumst
monoclon
antibodi
enhanc
viru
infect
flavivirus
combin
antibodi
abl
infect
cell
bear
fc
receptor
cross
bridg
mediat
antibodi
chana
et
al
peiri
et
al
schlesing
et
al
howev
use
monoclon
antibodi
demonstr
viru
epitop
antibodi
bound
also
import
brandt
et
al
found
flaviviru
type
common
determin
effect
second
cell
unabl
support
yfv
replic
even
antibodi
enhanc
attempt
consequ
presenc
fc
receptor
target
cell
surfac
alon
suffici
product
infect
use
monoclon
antibodi
therapeut
purpos
yet
infanc
like
antibodi
would
use
three
main
area
first
emerg
inject
neutral
antibodi
aid
recoveri
diseas
human
monoclon
antibodi
becom
avail
crawford
et
al
sikora
nevil
like
produc
fewer
problem
allerg
reaction
anim
experi
mous
indic
monoclon
antibodi
benefici
area
neutral
antibodi
abl
local
hsv
infect
prevent
spread
nervou
system
kapoor
et
al
promot
recoveri
ocular
infect
rector
et
al
protect
later
footpad
challeng
dix
et
al
antibodi
herpesviru
glycoprotein
protect
activ
intraven
inocul
monoclon
antibodi
specif
viru
hemagglutinin
found
protect
mice
invari
lethal
consequ
intracerebr
inject
influenza
wsn
action
howev
depend
upon
breakdown
bloodbrain
barrier
doherti
gerhard
abil
antibodi
function
way
simpli
correl
antiviru
action
measur
uitro
assay
nonneutr
antibodi
protect
mice
hsv
balachandran
et
al
rector
et
al
sindbi
viru
schmaljohn
et
al
mathew
roehrig
found
nonneutr
antibodi
could
also
protect
mice
japanes
equin
enceph
infect
antibodi
high
avid
protect
greater
effici
lower
avid
antibodi
direct
epitop
instrument
neutral
viru
effect
lower
dose
work
therefor
implic
tight
attach
well
site
combin
antigen
effici
protect
evid
suggest
complement
involv
protect
monoclon
antibodi
suggest
process
mediat
antibodydepend
cellmedi
cytolysi
balachandran
et
al
second
monoclon
antibodi
appli
select
avirul
virus
vaccin
purpos
rabi
viru
alreadi
describ
context
section
iv
heterogen
among
coxsacki
prabhakar
et
al
bluetongu
virus
may
permit
approach
antibodi
could
also
use
prepar
pure
subunit
vaccin
osterhau
et
al
final
combin
cytotox
agent
monoclon
antibodi
provid
specif
cell
kill
tool
davi
specif
cytotox
alreadi
demonstr
use
techniqu
blythman
et
al
krolick
et
al
youl
nevil
monoclon
antibodi
allow
us
view
fate
protein
infect
cell
synthesi
viru
assembl
continu
process
hint
interact
virusspecif
gene
product
cellular
machineri
use
monoclon
antibodi
provid
valuabl
insight
work
protein
enzym
target
host
immun
respons
evolv
reaction
respons
threedimension
structur
molecul
determin
work
extend
understand
viru
protein
structur
function
forego
discuss
emphas
specif
monoclon
antibodi
appli
studi
area
virolog
case
specif
antibodi
prove
use
even
permit
identif
relat
hitherto
unknown
protein
howev
specif
also
provid
basi
spuriou
cross
reactiv
normal
present
polyclon
serum
gener
appropri
absorb
monospecif
antiserum
recogn
mani
epitop
thu
coat
consider
area
protein
expos
surfac
singl
epitop
repeat
anoth
protein
would
cross
react
would
mask
vast
major
antibodi
react
target
antigen
case
monoclon
antibodi
target
molecul
may
one
site
antibodi
share
anoth
protein
consider
cross
reaction
could
detect
even
abscenc
extens
structur
homolog
calcul
crawford
et
al
primari
sequenc
four
amino
acid
unusu
size
antibodi
bind
site
might
occur
time
averag
cell
complement
protein
sequenc
howev
monoclon
antibodi
cross
reaction
would
expect
much
less
frequent
amino
acid
sequenc
must
express
surfac
molecul
antibodi
may
recogn
sequenc
given
conform
state
modif
protein
sequenc
normal
occur
random
antibodi
bind
site
often
larger
atassi
furthermor
would
difficult
anim
produc
antibodi
respons
epitop
like
cross
react
mere
random
basi
self
epitop
howev
could
perhap
toler
small
constitu
total
nonselfcrossreact
immun
respons
consequ
like
fortuit
cross
reaction
may
compar
rare
nevertheless
mani
cross
reaction
report
present
understood
review
lane
koprowski
sever
crawfordet
al
lane
hoeffler
involv
cross
rection
antigen
host
protein
antigen
harlow
et
al
former
case
good
reason
believ
antibodi
recogn
epitop
function
relat
host
protein
therefor
may
constrain
degre
overal
structur
similar
whether
repres
evolutionarili
conserv
structur
one
arisen
independ
converg
evolutionari
process
unknown
howev
cross
reaction
monoclon
antibodi
level
assum
indic
extens
structur
function
similar
without
consider
support
evid
applic
monoclon
antibodi
convent
serolog
reaction
permit
differenti
close
relat
serolog
crossreact
protein
alreadi
discuss
review
addit
process
describ
provid
entir
new
dimens
procedur
might
thu
permit
identif
function
relat
protein
bear
evid
cross
reaction
polyclon
sera
consequ
applic
monoclon
antibodi
improv
inform
obtain
well
establish
assay
procedur
may
also
lead
process
yield
entir
new
type
inform
